Skip to main content
Medicine LibreTexts

4.1: Glycolysis and the pyruvate dehydrogenase complex (PDC)

  • Page ID
    37840
  • \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \) \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)\(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\) \(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\)\(\newcommand{\AA}{\unicode[.8,0]{x212B}}\)

    Glycolysis can be divided into two parts, the preparative phase, which requires two ATP, and the energy producing phase, which produces NADH and ATP. The net result of glucose oxidation through glycolysis is two ATP, two NADH and two pyruvate. Briefly, the process of glycolysis starts with the phosphorylation of a glucose molecule (six-carbon sugar). The addition of a phosphate group traps the glucose in the cell where it will undergo isomerization to fructose 6-phosphate and further phosphorylation to fructose 1,6-bisphosphate. From here, fructose 1,6-bisphosphate is cleaved by aldolase B into two three-carbon compounds, which will ultimately produce two pyruvate. Under aerobic conditions, the pyruvate will enter the mitochondria and be oxidized to acetyl-CoA, which will enter the TCA cycle. When oxygen is limited or energy demands exceed oxygen delivery for ATP, the cell will rely on anaerobic glycolysis. In this case, lactate dehydrogenase will oxidize the NADH generated from glycolysis by reducing cytosolic pyruvate to lactate. Under these conditions oxygen is not required to reoxidize NADH, and therefore the process is referred to as anaerobic. The energy produced through this process is much less than through aerobic oxidation and therefore less favorable (figure 4.1).

    Glycolysis: Glucose, ATP arrow G-6-P, ADP with enzyme hexokinase. G-6-P arrow F-6-P with enzyme phosphoglucose isomerase. F-6-P, ATP arrow FBP, ADP with enzyme phosphofructokinase-1. FBP arrow DHAP and G-3-P with enzyme aldolase. DHAP bidirectional arrow G-3-P with enzyme triosephosphate isomerase. G-3-P, Pi, NAD+ arrow BPG, NADH, H+ with enzyme glyceraldehyde-3-phosphate dehydrogenase. BPG, ADP arrow 3-PG, ATP with enzyme phosphoglycerate kinase. 3-PG arrow 2-PG with enzyme phosphoglycerate mutase. 2-PG arrow PEP with enzyme enolase. PEP, ADP arrow pyruvate, ATP with enzyme pyruvate kinase.

    Figure 4.1: Summary of glycolysis. The three regulated steps of the process will be the focus, and those are catalyzed by the enzymes glucokinase/hexokinase, phosphofructokinase 1 (PFK1), and pyruvate kinase. All other steps in glycolysis are reversible (as indicated by the arrows) and are also used in gluconeogenesis.

    Regulation of glycolysis

    Glycolysis in the liver has three primary regulated and irreversible steps (figure 4.1).

    Glucokinase: Glucose to glucose 6-phosphate

    In the liver, glucose is taken up through an insulin-independent process mediated by GLUT2 transporters. Following this, glucose must be phosphorylated to be trapped in the cell. The phosphorylation of glucose to glucose 6-phosphate is catalyzed by glucokinase (figure 4.2) in the liver.

    Glucose arrow with enzyme hexokinase or glucokinase and ATP arrow ADP to glucose 6-phosphate. Glucose 6-phosphate arrow with enzyme Glucose 6-phosphate (in endoplasmic reticulum) with loss of Pi to glucose.

    Figure 4.2: Regulatory step committed by hexo or glucokinase. The first regulatory step in glycolysis is the phosphorylation of glucose by hexo or glucokinase. The reverse reaction, which is part of gluconeogensis, is catalyzed by glucose 6-phosphatase.

    In skeletal muscle, and most other peripheral tissues, glucose is phosphorylated by hexokinase.

    Glucokinase and hexokinase perform the same reaction but have very different enzyme kinetics. Glucokinase (in the liver) has a higher \(K_m\) (lower affinity for glucose) when compared to hexokinase. In the liver, this enzyme will phosphorylate glucose only when glucose concentrations are high such as in the fed state. Glucokinase also has a high \(V_{max}\) and is therefore not rapidly saturated. This allows for continuous glucose uptake when glucose levels are high allowing for glucose storage and the rapid removal of glucose from circulation, minimizing the likelihood of hyperglycemia. In contrast, hexokinase has a lower \(K_m\) and a high affinity for glucose (figure 4.3). This enzyme becomes rapidly saturated over a very small range of glucose concentrations.

    X-axis Glucose Concentration (mmol/L) labeled from 0 to 20 in increments of 5 and y-axis enzyme activity. Glucokinase follows a parabola shape and flattens over approximately 20 on the x-axis. The Km of Glucokinase is at 10 on the x-axis. Hexokinase follows a rectangular hyperbola shape at a third of the height of glucokinase and flattens over approximately 1 on the x-axis. The Km of Hexokinase is at approximately 1 on the x-axis. An arrow points up at 5 and is labeled concentration of fasting blood glucose.

    Figure 4.3: Comparison of glucokinase and hexokinase kinetics.

    Regulation of glucokinase and hexokinase

    Hexokinase is regulated through feedback inhibition where glucose 6-phosphate will compete with glucose for substrate binding. On the other hand, glucokinase is regulated through an alternative mechanism involving the glucokinase regulatory binding protein (GKRP). This protein will bind glucokinase and trap it in the nucleus. When glucose is high, glucokinase is released into the cytosol to phosphorylate glucose. As fructose 6-phosphate levels increase, this will inhibit the glucokinase reaction by enhancing the rebinding of glucokinase to GKRP, trapping it in the nucleus (figure 4.4).

    Glucose passes through the plasma membrane through the GLUT-2 channel. In the cytosol, glucose arrow G6P arrow F6P arrow pyruvate. Glucokinase (inactive) and Glucokinase regulatory protein pictured in a nucleus with bidirectional arrows pointing to free GK in between glucose and G6P. Glucose activates the reaction from bound to free GK and F6P activates the reaction from free to bound GK.

    Figure 4.4: Regulation of glucokinase by glucokinase regulatory protein.

    Phosphofructokinase 1 (PFK1): Fructose 6-phosphate to fructose 1,6-bisphosphate (figure 4.5)

    Glucose 6-phosphate bidirectional arrow with enzyme phosphoglucose isomerase to fructose 6-phosphate bidirectional arrow fructose 1,6-bisphosphate. Fructose 6-phosphate forward arrow with enzyme phosphofructokinase-1 and ATP arrow ADP to fructose 1,6-bisphosphate. F-2, 6-BP +. Fructose 1,6-bisphosphate backwards arrow with enzyme fructose 1,6-bisphosphate and loss of Pi to fructose 6-phosphate. Fructose 6-phosphate forward arrow with enzyme phosphofructokinase-2 fructose bisphosphatase-2 (bifunctional enzyme) and ATP arrow ADP to fructose 2,6-bisphosphate. Fructose 2,6-bisphosphate backwards arrow with loss of Pi to fructose 6-phosphate.

    Figure 4.5: Regulation of PFK1 by fructose 2,6-bisphosphate generated by PFK2.

    Following glucose phosphorylation to glucose 6-phosphate, the glucose 6-phosphate can be used for glycogen synthesis or the pentose phosphate pathway. Substrate that continues through glycolysis is isomerized to fructose 6-phosphate, which is the substrate for the reaction catalyzed by phosphofructokinase 1 (PFK1).

    Regulation of phosphofructokinase 1 (PFK1)

    Regulation of phosphofructokinase 1 is primarily through allosteric activation by AMP and fructose 2,6-bisphosphate. High AMP levels would indicate a lack of energy within the cell, and this would increase flux through glycolysis by enhancing the activity of PFK1. PFK1 is also inhibited by citrate and ATP; levels of these compounds are indicative of a high energy state, suggesting there are sufficient oxidation productions and glucose is diverted to storage pathways.

    Fructose 2,6-bisphosphate is an important regulator of glycolysis, formed by a shunt in the glycolytic pathway. When there is an excess of fructose 6-phosphate in the cell, this substrate is accepted by phosphofructokinase 2 (PFK2) and converted to fructose 2,6-bisphosphate. This compound, fructose 2,6-bisphosphate, functions as an allosteric activator of PFK1. Additionally, PFK2 can be regulated by covalent modification such as phosphorylation. PFK2 is a bifunctional enzyme and only functions as a kinase when insulin is high and it is dephosphorylated. Under fasted conditions, when glucagon is high, this leads to the phosphorylation and inactivation of PFK2; when the enzyme is phosphorylated, it functions as a phosphatase and is referred to as fructose 2,6-bisphosphatase (FBP2) (figure 4.5).

    Pyruvate kinase: Phosphoenol pyruvate to pyruvate

    Following the synthesis of fructose 1,6-phosphate, aldolase will cleave this substrate into dihydroxyacetone and glyceraldehyde 3-phosphate. These three carbon compounds will be used to synthesize pyruvate in the final regulatory step of the pathway catalyzed by pyruvate kinase (PK).

    Regulation of pyruvate kinase (PK)

    The final regulatory step of glycolysis is the reaction catalyzed by pyruvate kinase. The enzyme converts phosphoenol pyruvate (PEP) to pyruvate. PK can be regulated by phosphorylation and allosteric means. PK is subject to feed-forward activation by fructose 1,6-bisphosphate, which allosterically activates the enzyme, increasing flux in the downward direction. As energy levels in the cell increase, ATP levels will reduce enzyme activity through allosteric inhibition (figure 4.6). PK can also be regulated through phosphorylation. Similar to PFK2, PK is dephosphorylated and active in the fed state but phosphorylated during the fasted state, which renders the enzyme inactive; the phosphorylation is glucagon mediated.

    Phosphoenolpyruvate forward arrow with enzyme pyruvate kinase and ADP arrow ATP to pyruvate. Mitochondrial pyruvate carrier forward arrow pyruvate. Fructose 1,6BP activates pyruvate kinase. ADP and alanine inhibits pyruvate kinase.

    Figure 4.6: Regulation of pyruvate kinase phosphorylation and fructose 1,6-bisphosphate.

    Movement of NADH from the cytosol to the mitochondria

    The NADH generated in the cytosol by glycolysis must be oxidized back to NAD+ in order to maintain a pool of NAD+ needed for glucose oxidation. As NADH oxidation takes place in the mitochondria, and the membrane is not permeable to NADH, two shuttles are used to move cytosolic NADH into the mitochondria. These processes are a way to get energy out of cytoplasmic NADH into the mitochondria.

    Glycerol 3-phosphate shuttle

    The glycerol 3-phosphate shuttle is the major shuttle used in most tissues to move NADH from the cytosol to the mitochondria for oxidation. In this pathway, NAD+ is regenerated by glycerol 3-phosphate dehydrogenase, which transfers electrons from NADH to dihydroxyacetonephosphate to generate glycerol 3-phosphate. Glycerol 3-phosphate can diffuse across the mitochondrial membrane where it will donate electrons to membrane bound FAD (bound to succinate dehydrogenase) (figure 4.7).

    Left: Glycerol 3-phosphate bidirectional arrow with enzyme glycerol 3-phosphate dehydrogenase (GPDH) and NADH bidirectional arrow NAD+ to dihydroxyacetone phosphate (DHAP). Glycerol 3-phosphate second arrow to DHAP. Right: A vertical plasma membrane separating the cytosol (left) and mitochondrial matrix (right) with Coenzyme Q (oxidized) arrow pointing up to Coenzyme Q (reduced). Middle: Clockwise circular arrows between FADH2 and FAD with enzyme mitochondrial glycerol 3-phosphate dehydrogenase (flavoprotein) (mGPDH). The circular arrows are touching the second arrow from glycerol 3-phosphate to DHAP and the arrow between oxidized and reduced coenzyme Q.

    Figure 4.7: Glycerol 3-phosphate shuttle.

    Malate-aspartate shuttle

    Many tissues also contain the malate-aspartate shuttle, which can also carry cytosolic NADH into the mitochondria. Cytosolic NADH is used to reduce oxaloacetate (OAA) to malate, which can cross the mitochondrial membrane. Once inside the mitochondria, malate can be oxidized to OAA to produce NADH. OAA canʼt pass through the mitochondrial membrane, so it requires transamination to aspartate, which can be shuttled into the cytosol to regenerate the cycle (figure 4.8).

    Mitochondrial membrane with a glutamate/aspartate transporter and dicarboxylate transporter. The top is the intermembrane space and the bottom half is the matrix. Glutamate from intermembrane space arrow through glutamate/aspartate transporter to matrix bidirectional arrow with enzyme aspartate aminotransferase (AST) to aspartate arrow through glutamate/aspartate transporter to intermembrane space bidirectional arrow with enzyme AST to glutamate. Dicarboxylate transporter arrow malate into the intermembrane space bidirectional arrow with enzyme malate dehydrogenase and NADH bidirectional arrow NAD+ to oxaloacetate bidirectional arrow α-ketoglutarate bidirectional arrow through dicarboxylate transporter into the matrix. Α-ketoglutarate bidirectional arrow with enzyme AST to oxaloacetate.

    Figure 4.8: Malate-aspartate shuttle.

    Pyruvate dehydrogenase complex

    Under aerobic conditions, the pyruvate produced by glycolysis will be oxidized to acetyl-CoA using the pyruvate dehydrogenase complex (PDC). This enzyme is a key transition point between cytosolic and mitochondrial metabolism. This complex is composed of three subunits, which require the cofactors thiamine pyrophosphate, lipoic acid, and FADH\(_2\); NADH is also required for the reaction to move forward. The enzyme is highly regulated by both covalent and allosteric regulation. Deficiencies of the PDC can be recessive or X-linked (depending on the subunit deficient) and present with symptoms of lactic acidosis after consuming a meal high in carbohydrates. This metabolic deficiency can be managed by delivering a ketogenic diet and bypassing glycolysis all together.

    Regulation of the pyruvate dehydrogenase complex (PDC)

    The PDC is regulated by allosteric and covalent regulations. The complex itself can be allosterically activated by pyruvate and NAD+. Elevation of substrate (pyruvate) will enhance flux through this enzyme as will the indication of low energy states as triggered by high NAD+ levels. The PDC is also inhibited by acetyl-CoA and NADH directly. Product inhibition is a very common regulatory mechanism, and high NADH would signal sufficient energy levels, therefore decreasing activity of the PDC.

    The PDC is also regulated through covalent modification. Phosphorylation of the complex will decrease activity of the enzyme.

    The enzyme responsible for phosphorylation of the PDC is pyruvate dehydrogenase kinase. The kinase is regulated inversely to the PDC (figure 4.9). The kinase is most active when acetyl-CoA and NADH are high. These compounds will stimulate the kinase to phosphorylate and inactivate the PDC. The PDC can be dephosphorylated by a calcium-mediated phosphatase.

    PDC inactive arrow phosphatase arrow PDC active arrow kinase, ATP arrow PDC inactive, ADP. Pi leaves between phosphatase and PDC active. Calcium activates phosphatase. NADH and acetyl-CoA activate kinase. Pyruvate and ADP inhibit kinase. Under PDC active, coASH to CO2. Pyruvate and NAD+ activate and acetyl-CoA and NADH inhibit.

    Figure 4.9: Regulation of the pyruvate dehydrogenase complex (PDC).

    Summary of pathway regulation

    Metabolic pathway Major regulatory enzyme(s) Allosteric effectors Hormonal effects

    Glycolysis (pyruvate oxidation)

    Glucokinase (liver)

    GKRP

     
    Hexokinase Glucose 6P (-)  
    PFK-1

    Fructose 2,6-BP, AMP (+)

    Citrate (-)

    Insulin/Glucagon ratio >1 → dephosphorylation of PFK2 and increased production of F 2,6-BP
    Pyruvate kinase

    Fructose 1,6-BP (+)

    ATP, alanine (-)

    Insulin/Glucagon ratio >1 → dephosphorylation
    Pyruvate dehydrogenase complex PDC

    Pyruvate, NAD+ (+)

    Acetyl-CoA, NADH, ATP (-)

    Insulin/Glucagon ratio >1 → dephosphorylation

    Table 4.1: Summary of pathway regulation.

    References and resources

    Text

    Ferrier, D. R., ed. Lippincott Illustrated Reviews: Biochemistry, 7th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2017, Chapter 6: Bioenergetics and Oxidative Phosphorylation: Section V, VI, Chapter 8: Introduction to Metabolism and Glycolysis, Chapter 9: TCA Cycle and Pyruvate Dehydrogenase Complex: Section IIA, IIB, Chapter 11: Glycogen Metabolism: Section V, VI, Chapter 16: Fatty Acid Ketone Body and TAG Metabolism: Section II, IV, V, Chapter 23: Metabolic Effect of Insulin and Glucagon, Chapter 25: Diabetes Mellitus.

    Le, T., and V. Bhushan. First Aid for the USMLE Step 1, 29th ed. New York: McGraw Hill Education, 2018, 72–78, 85–89.

    Lieberman, M., and A. Peet, eds. Marks' Basic Medical Biochemistry: A Clinical Approach, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018, Chapter 2: The Fed or Absorptive State, Chapter 19: Basic Concepts of Regulation: Section IV.A.1.2, Chapter 20: Cellular Bioenergetics, Chapter 22: Generation of ATP from Glucose: Section I.A.B.C, III, Chapter 24: Oxidative Phosphorylation and the ETC: Section I.E, II, III, Chapter 31: Synthesis of Fatty Acids: Section I.A.B, IV, V.

    Figures

    Grey, Kindred, Figure 4.1 Summary of glycolysis... 2021. https://archive.org/details/4.1_20210924. CC BY 4.0.

    Grey, Kindred, Figure 4.2 Regulatory step committed by hexo or glucokinase... 2021. https://archive.org/details/4.2_20210924. CC BY 4.0.

    Grey, Kindred, Figure 4.4 Regulation of glucokinase by glucokinase regulatory protein. 2021. https://archive.org/details/4.4_20210924. CC BY 4.0. Added ion channel by Léa Lortal from Noun Project and sphere by Pablo Rozenberg from Noun Project.

    Grey, Kindred, Figure 4.5 Regulation of PFK1 by fructose 2,6-bisphosphate generated by PFK2. 2021. https://archive.org/details/4.5-new. CC BY 4.0.

    Grey, Kindred, Figure 4.6 Regulation of pyruvate kinase phosphorylation and fructose 1,6-bisphosphate. 2021. https://archive.org/details/4.6-new. CC BY 4.0.

    Grey, Kindred, Figure 4.7 Glycerol 3-phosphate shuttle. 2021. https://archive.org/details/4.7_20210924. CC BY 4.0. Added ion channel by Léa Lortal from the Noun Project.

    Grey, Kindred, Figure 4.8 Malate-aspartate shuttle. 2021. https://archive.org/details/4.8_20210924. CC BY 4.0.

    Lieberman M, Peet A. Figure 4.3 Comparison of glucokinase and hexokinase kinetics. Adapted under Fair Use from Marks' Basic Medical Biochemistry. 5th Ed. pp 154. Figure 9.4 A comparison between hexokinase I and glucokinase. 2017.

    Lieberman M, Peet A. Figure 4.9 Regulation of the PDC. Adapted under Fair Use from Marks' Basic Medical Biochemistry. 5th Ed. pp 471. Figure 23.15 Regulation of pyruvate dehydroenase complex (PDC). 2017.


    This page titled 4.1: Glycolysis and the pyruvate dehydrogenase complex (PDC) is shared under a CC BY-NC-SA 4.0 license and was authored, remixed, and/or curated by Renee J. LeClair (Virginia Tech Libraries' Open Education Initiative) .

    • Was this article helpful?